Onyx Biotec Ltd launched its IPO on November 13, 2024.
The Onyx Biotec IPO is a book-built issue that aims to raise ₹29.34 crores through a fresh issue of 48.1 lakh shares. With this IPO, the company offers shares priced between ₹58 and ₹61 each, with a minimum lot size of 2,000 shares for retail investors. The IPO allotment is expected on November 19, with listing on NSE SME set for November 21.
Quick steps to apply for the Onyx Biotec Limited IPO!
Onyx Biotec IPO Timeline Details (Tentative Schedule)
| Detail | Information |
IPO Opening Date | November 13, 2024 |
IPO Closing Date | November 18, 2024 |
Listing Date | November 21, 2024 |
Face Value | ₹10 per share |
Price Range | ₹58 to ₹61 per share |
Lot Size | 2,000 shares |
Total Issue Size | 4,810,000 shares (₹29.34 Cr) |
Fresh Issue | 4,810,000 shares (₹29.34 Cr) |
IPO Segment | Book Built Issue IPO |
| Maximum Bid Quantity for QIB Investors | 32,00,000 equity shares |
Maximum Bid Quantity for NIB Investors | 22,88,000 equity shares |
Listing At | NSE SME |
Name of the Registrar | MAS Services Limited |
Get to Know Onyx Biotec Limited
Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company. It specialises in the manufacturing of sterile water for injections. The company provides a range of dry powder injections and dry syrups for both Indian and international markets. Onyx Biotec operates two manufacturing units in Solan, Himachal Pradesh.
Ready to Invest in Onyx Biotec IPO? Open a free demat account and trading account!
Onyx Biotec Limited IPO: Key Details
- IPO Opening Date: November 13, 2024
- IPO Closing Date: November 18, 2024
- IPO Allotment Date: November 19, 2024
- IPO Price Band: ₹58 to ₹61 per share
- IPO Face Value: ₹10
- IPO Lot Size: 2,000 shares
- Refunds Initiated: November 20, 2024
- Shares Credited to Demat: November 20, 2024
- Listing Date: November 21, 2024
Onyx Biotec Ltd: Financial Highlights for 2024
Onyx Biotec Limited has shown notable growth, with a 35.99% increase in revenue and a 64.35% rise in profit after tax (PAT) between March 31, 2023, and March 31, 2024.
Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
31 May 2024 | 7,476.57 | 1,054.11 | 130.77 | 2,618.64 | 1,286.42 | 3,156.14 |
31 Mar 2024 | 7,413.58 | 5,387.43 | 303.16 | 2,487.87 | 1,155.65 | 3,078.04 |
31 Mar 2023 | 5,872.36 | 3,961.65 | 184.46 | 1,820.16 | 1,230.00 | 2,922.83 |
31 Mar 2022 | 3,683.84 | 4,498.09 | 335.29 | 1,637.59 | 1,047.43 | 1,224.39 |
Amount in ₹ Lakhs
SWOT Analysis of Onyx Biotec Limited IPO: Key Strengths, Risks, and Opportunities for Investors
The Onyx Biotec Limited IPO offers an exciting chance for investors but comes with its own strengths and risks. The company has shown a strong growth in revenue and profits. However, idue to its nature of working, it may be subject to to production disruptions and economic swings.
On the bright side, there are growth opportunities in expanding its contract manufacturing services and entering new markets.
FAQs | Onyx Biotec Ltd IPO
Onyx Biotec Ltd, founded in 2005, manufactures sterile water for injections and provides pharmaceutical contract manufacturing services.
The bidding date for Onyx Biotec IPO is from November 13, 2024, to November 18, 2024.
The IPO lot size for Onyx Biotec is 2,000 shares.
You can check the allotment of IPO shares through the official registrar’s website. The register of Onyx Biotec IPO is Mas Services Limited.
The IPO face value is set at ₹10 per share.
The Onyx Biotech Limited IPO launch date is November 13 and will close on November 18. It is expected to list on November 21.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.